Evidence map›Paper›PMID 34242797›Full record

ArticleJournal of pharmacological and toxicological methods

The use of hypercapnic conditions to assess opioid-induced respiratory depression in rats.

Morgan L Crowley, Luis F Restrepo, Lea R Gamez-Jimenez, Avi Patel, Tobias Braun, Victoria L C Pallares, Nicholas P Ho, Morgan E Reeves, Christopher R McCurdy, Lance R McMahon and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmacological and toxicological methods. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Morgan L CrowleyDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Luis F RestrepoDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Lea R Gamez-JimenezDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Avi PatelDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Tobias BraunDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Victoria L C PallaresDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Nicholas P HoDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Morgan E ReevesDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Christopher R McCurdyDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, USA; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA; Translational Drug Development Core, Clinical and Translational Sciences Institute, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Lance R McMahonDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Takato HiranitaDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA. Electronic address: takatohiranita@cop.ufl.edu.
University of Florida · US

Funding

Opioid use disorders: UF Pharmacy medications discovery and developmentUG3DA048353 · NIDA · UNIVERSITY OF FLORIDA · PI MCCURDY, CHRISTOPHER R, MCMAHON, LANCE R. · 2019 to 2020
$3.6M
Kratom alkaloids: in vitro and in vivo pharmacological mechanismsR01DA047855 · NIDA · UNIVERSITY OF FLORIDA · PI MCCURDY, CHRISTOPHER R, MCMAHON, LANCE R. · 2019 to 2023
$3.6M
NIDA NIH HHS R01 DA047855NIDA NIH HHS UG3 DA048353
6 · The paper itself

Abstract

introductionWhole-body plethysmography (WBP) in unrestrained, non-anesthetized rodents is a preclinical method to assess the respiratory depressant effects of opioids, the leading cause of opioid overdose death in humans. However, low baseline respiration rates under normocapnic conditions (i.e., "floor" effect) can render the measurement of respiratory decreases challenging. We assessed hypercapnia-induced increases in respiration as a strategy to assess opioid-induced decreases in respiration in rats.

methodsWBP was used to assess respiration frequency, tidal volume and minute volume in the presence of normocapnic and hypercapnic (8% CO RESULTS AND DISCUSSION: Hypercapnia-induced increases in respiratory parameters (frequency, minute volume, and tidal volume) were decreased by fentanyl at doses that did not decrease the same parameters under the normocapnic conditions. These findings show that hypercapnia increases sensitivity to respiratory depressant effects of fentanyl, as compared with assessments during the rat diurnal period when activity and breathing rate are generally low, i.e., there is a floor effect. The current approach is highly sensitive to opioid-induced respiratory depression, and therefore provides a useful method for assessment in a pre-clinical setting.

Indexed as

Analgesics, OpioidRespiratory InsufficiencyAnimalsFentanylHypercapniaRatsTidal VolumeAnalgesics, OpioidFentanylAntinociceptionFrequencyHotplateHypercapnicMethodsMinute volumeOpioidsPotency ratioRespirationSafety window

Identifiers

PMID34242797
PMCPMC8494486
OpenAlexW3181629619

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.